Costa Bruno Silva, Cavalcanti-Mendes George de Albuquerque, Abreu Marcelo Sartori de, Sousa Atos Alves de
Department of Neurosurgery, Hospital Santa Casa de Belo Horizonte, Belo Horizonte, MG, Brazil.
Arq Neuropsiquiatr. 2011 Apr;69(2A):217-20. doi: 10.1590/s0004-282x2011000200015.
Dural substitutes are used to achieve watertight closure of the dura mater when adequate closure is not possible. The purpose of this study was to evaluate the efficacy and safety of a new collagen matrix dural substitute (Duradry, Technodry, Belo Horizonte MG) in the repair or expansion of cranial and spinal dura mater.
Thirty patients, operated on between March and September, 2008, were studied. Surgical records were reviewed for sex, age, location of graft, technique, and presence of fistula or infection. The patients were followed up for at least 3 months, and presence of complications, such as cerebrospinal fluid leakage, infection, aseptic meningitis hydrocephalus, pseudomeningocele, was analyzed.
Only one patient presented cerebrospinal fluid fistula. No patients presented wound infections, hydrocephalus, pseudomenigocele, meningitis, brain abscesses or signs of toxicity related to the dural substitute.
The new dural substitute used in this study is effective and safe, and the initial results are similar to those of other dural substitutes reported in the literature.
当无法进行充分缝合时,硬脑膜替代物用于实现硬脑膜的水密性闭合。本研究的目的是评估一种新型胶原基质硬脑膜替代物(Duradry,Technodry,贝洛奥里藏特米纳斯吉拉斯州)在修复或扩展颅和脊髓硬脑膜方面的有效性和安全性。
研究了2008年3月至9月间接受手术的30例患者。回顾手术记录,了解患者的性别、年龄、移植物位置、技术以及是否存在瘘管或感染。对患者进行至少3个月的随访,并分析并发症的发生情况,如脑脊液漏、感染、无菌性脑膜炎、脑积水、假性脑膜膨出。
仅1例患者出现脑脊液瘘。无患者出现伤口感染、脑积水、假性脑膜膨出、脑膜炎、脑脓肿或与硬脑膜替代物相关的毒性体征。
本研究中使用的新型硬脑膜替代物有效且安全,初步结果与文献中报道的其他硬脑膜替代物相似。